HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.
Ontology highlight
ABSTRACT: Members of the heterochromatin protein 1 family (HP1α, β and γ) are mostly associated with heterochromatin and play important roles in gene regulation and DNA damage response. Altered expression of individual HP1 subtype has profound impacts on cell proliferation and tumorigenesis. We analyzed the expression profile of HP1 family by data mining using a published microarray data set coupled with retrospective immunohistochemistry analyses of archived breast cancer biospecimens. We found that the patient group overexpressing HP1β mRNA is associated with poorly differentiated breast tumors and with a significantly lower survival rate. Immunohistochemical staining against HP1α, HP1β and HP1γ shows that respective HP1 expression level is frequently altered in breast cancers. 57.4-60.1% of sampl
SUBMITTER: Lee YH
PROVIDER: S-EPMC4358987 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
ACCESS DATA